Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

BSE: 524742

Small Cap

Pharma Sector

₹2583.00

+12.40

(+0.48%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Caplin Point Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+51%

Searches for Caplin Point Laboratories on INDmoney have increased by 51% over the last 30 days.

Investment activity on INDmoney

+173.93%

Investment activity in Caplin Point Laboratories among INDmoney users has increased by 173.93% over the last 30 days.

Among the most traded stocks

382nd

Caplin Point Laboratories was the 382nd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

42 days

INDmoney investors hold Caplin Point Laboratories shares for an average of 42 days.

Key Events for Caplin Point Laboratories

Upcoming Events

Ex-Dividend Date18/09/2026
Record Date18/09/2026

Last Dividend Declared

₹4.00 per share, declared on 12/08/2026

View Dividend History

Caplin Point Laboratories Stock Performance

as on September 16, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,490.50
    ₹2,606.70
    downward going graph

    3.58%

    Downside

    0.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,500.30
    ₹2,877.30
    downward going graph

    41.92%

    Downside

    11.39%

    Upside

    downward going graph

Caplin Point Laboratories share price movements today

Previous Close
₹2,570.60
Open
₹2,581.00
Volume
2.12L
Upper Circuit
₹3,084.70
Lower Circuit
₹2,056.50
Day's Low - High
₹2,490.50 - ₹2,606.70
52 Week Low - High
₹1,500.30 - ₹2,877.30

Caplin Point Laboratories Historical Returns

1 Month Return
+ 1.93 %
3 Month Return
+ 8.11 %
1 Year Return
+ 14.38 %
3 Year Return
+ 146.3 %
5 Year Return
+ 188.1 %

Caplin Point Laboratories Fundamentals

as on September 16, 2026 at 4:01 pm IST

Market Cap

₹19,539.57 Cr

Return on Equity (ROE)

21.14

PE Ratio (TTM)

31.47

Return on capital employed (ROCE)

26.98

Industry PE ratio

51.81

Beta (LTM)

0.89

P/B Ratio

5.58

Dividend Yield

0

PEG Ratio

2.39

Quarterly Earnings Growth YOY

18.79

EPS (TTM)

85.49

Book Value

443.4

Caplin Point Laboratories Stock Valuation

as on September 16, 2026 at 4:01 pm IST

Caplin Point Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (31.47x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (40.01x)

December 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 31.47x

Caplin Point Laboratories Technical Analysis

Track how Caplin Point Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish11
Bullish2
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-1.4
Bearish
CCI (20)
-545.55
Bullish
RSI (14)
38.84
Neutral
Momentum (10)
-7.1
Bearish
ADI (14)
17.21
Neutral
Ultimate Oscillator (7,14,28)
73.69
Bullish

Moving Averages

Name

Value

Action

SMA (20)
2585.87
Bearish
EMA (20)
2586.29
Bearish
VWMA (20)
2585.85
Bearish
SMA (50)
2589.83
Bearish
EMA (50)
2588.58
Bearish
SMA (200)
2587.41
Bearish
EMA (200)
2585.78
Bearish
KAMA (200)
2590.38
Bearish
DEMA (200)
2591.57
Bearish

Caplin Point Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Caplin Point Laboratories Ltd image
Caplin Point Laboratories Ltd
BUY19,539.5737.62%0.516492,187
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,206.82-4.25%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,120.3612.3%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA6,101.01-7.47%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,764.7444.58%0.682811,703
See all

Market expectation of Caplin Point Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Caplin Point Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
410.06
435.5
453.22
458.96
483.1
492.96
502.45
510.22
534.04
542.77
600.16
610.36
Other Income
20.54
17.2
17.35
18.58
20.77
31.36
25.82
23.17
30.39
33.68
28.36
33.55
Total Income
430.6
452.7
470.57
477.54
503.87
524.32
528.27
533.39
564.43
576.45
628.52
643.91
Expenses
272.66
293.22
307.99
307.15
318.44
330.68
334.39
332.46
344.87
353.1
395.92
396.89
Operating Profit
137.4
142.28
145.23
151.81
164.66
162.28
168.06
177.76
189.17
189.67
204.24
213.47
Operating Profit Margin %
33.51%
32.67%
32.04%
33.08%
34.08%
32.92%
33.45%
34.84%
35.42%
34.94%
34.03%
34.97%
Profit Before Interest, Tax and Depreciation
157.94
159.48
162.58
170.39
185.43
193.64
193.88
200.93
219.56
223.35
232.6
247.02
Interest
0.18
0.17
0.15
0.05
0.21
0.18
0.17
0.18
0.16
0.18
0.36
0.18
Depreciation
11.76
13.9
16.4
15.96
16.76
16.2
17.04
16.29
18.4
19.28
18.8
21.62
Profit Before Tax
146
145.41
146.03
154.38
168.46
177.26
176.67
184.46
201
203.89
213.44
225.22
Tax Paid
29.86
25.59
24.8
29.46
37.65
37.19
31.39
33.7
40.77
38.03
40.56
46.13
Profit After Tax
116.14
119.82
121.23
124.92
130.81
140.07
145.28
150.76
160.23
165.86
172.88
179.09
Total Net profit including share of profit / Loss from associate company
116.14
119.82
121.23
124.92
130.81
140.07
145.28
150.76
160.23
165.86
172.88
179.09
EPS
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
20.32
21.56
22.38
23.27
Actual EPS
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
20.32
21.56
22.38
23.27
Adjusted EPS
15.13
15.44
16.01
16.32
17.22
18.28
18.75
20.1
20.32
21.56
22.38
23.27
Diluted EPS
15.06
15.39
15.9
16.24
17.12
18.19
18.69
20.03
20.25
21.51
22.31
23.21

Caplin Point Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
539.84
648.69
863.2
1,061.29
1,269.41
1,466.73
1,694.1
1,937.47
2,187.19
Other Income
12.67
19.03
41.33
23.54
38.75
56.06
67.21
96.43
115.58
Total Income
552.51
667.72
904.53
1,084.83
1,308.16
1,522.79
1,761.31
2,033.9
2,302.77
Expenses
345.07
417.36
603.13
732.65
874.74
1,025.67
1,142.66
1,290.55
1,426.34
Operating Profit
194.77
231.33
260.07
328.64
394.67
441.06
551.44
646.92
760.85
Operating Profit Margin %
36.08%
35.66%
30.13%
30.97%
31.09%
30.07%
32.55%
33.39%
34.79%
Profit Before Interest, Tax and Depreciation
207.43
250.36
301.4
352.18
433.42
497.12
618.65
743.35
876.43
Interest
0.06
0.06
0.32
1.59
0.7
0.78
0.78
0.61
0.87
Depreciation
19
23.43
31.62
36.97
46.9
44.99
53.44
65.96
72.77
Profit Before Tax
188.37
226.87
269.46
313.62
385.82
451.35
564.43
676.78
802.79
Tax Paid
43.74
50.32
54.38
62.18
77.37
74.36
103.01
135.69
153.06
Profit After Tax
144.64
176.56
215.08
251.44
308.45
376.99
461.42
541.09
649.73
Total Net profit including share of profit / Loss from associate company
144.64
176.56
215.08
251.44
308.45
376.99
461.42
541.09
649.73
EPS
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
84.36
Actual EPS
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
84.36
Adjusted EPS
19.16
23.35
28.42
32.03
39.61
49.62
60.19
70.57
84.36
Diluted EPS
19.06
23.23
28.2
31.71
39.26
49.18
59.9
70.25
84.11

Caplin Point Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
42.4
67.61
66.49
83.42
44.68
268.61
336.73
271.37
318.39
432.37
523.24
Cash Flow from Investing Activities
-5.72
-36.1
-69.02
-99.74
-54.33
-29.68
-376.86
-216.4
-319.18
-333.3
-582.05
Cash Flow from Financing Activities
-13.95
-6.75
-11.6
89.79
79.76
-23.98
-40.68
-28.17
-38.07
-38.32
-46.46
Net Cash Flow
22.73
24.76
-14.14
73.48
70.11
214.95
-80.81
26.8
-38.86
60.75
-105.27

Caplin Point Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
70.62%
70.62%
70.56%
70.56%
70.56%
70.56%
70.56%
70.57%
70.57%
70.57%
70.57%
DII
0.43%
1.09%
1.49%
1.84%
2.11%
2.01%
2.22%
2.1%
2.05%
2.14%
2.49%
FII
2.85%
3.34%
3.37%
3.7%
4.86%
5.73%
6.17%
6.51%
6.59%
6.15%
5.75%
Public
26.1%
24.95%
24.57%
23.9%
22.47%
21.7%
21.05%
20.82%
20.79%
21.14%
21.18%
Total Outstanding Shares
7,59,41,746
7,59,41,746
7,60,10,296
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
7,60,11,696
Total Shareholders
79,438
81,409
80,411
96,123
92,702
96,387
94,169
93,753
93,705
93,896
94,385

Mutual Funds Buying / Exiting Caplin Point Laboratories

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Caplin Point Laboratories

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Caplin Point Laboratories

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

UTI Aggressive Hybrid Fund-Growth - Direct

UTI Aggressive Hybrid Fund-Growth - Direct

₹54.14 Cr

₹12.27 Cr (-18.47%)

0.78%

UTI Healthcare Fund-Growth Option- Direct

UTI Healthcare Fund-Growth Option- Direct

₹45.16 Cr

₹10.11 Cr (-18.30%)

3.05%

UTI Large & Mid Cap Fund-Growth Option - Direct

UTI Large & Mid Cap Fund-Growth Option - Direct

₹70.61 Cr

₹6.73 Cr (-8.70%)

1.06%

UTI Retirement Fund- Direct

UTI Retirement Fund- Direct

₹22.12 Cr

₹4.19 Cr (-15.94%)

0.46%

UTI Small Cap Fund Direct Growth

UTI Small Cap Fund Direct Growth

₹93.22 Cr

₹0.22 Cr (-0.24%)

1.67%

Caplin Point Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Caplin Point Laboratories.

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 15.78% since last year same period to ₹176.91Cr in the Q1 2026-2027. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 4% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Caplin Point Laboratories Ltd Dividends August,2026

    In the quarter ending June 2026, Caplin Point Laboratories Ltd has declared dividend of ₹4.00 per share on 12 Aug 2026 - translating a dividend yield of 0.31%.

    Read More about Dividends

Indices Featuring Caplin Point Laboratories Stock

Check stock indices that include Caplin Point Laboratories.

BSE Healthcare

₹50,434.00

-44.81 (▲0.09%)

Nifty MidSmallcap 400

₹20,744.90

-5.80 (▲0.03%)

BSE 500

₹35,276.25

+106.63 (▲0.30%)

Nifty Smallcap 250

₹17,863.30

-29.50 (▲0.16%)

S&P BSE 400 MidSmallCap

₹12,407.25

+0.41 (▲0%)

Nifty 500

₹22,532.00

+54.55 (▲0.24%)

S&P BSE 250 SmallCap

₹7,043.79

-8.83 (▲0.13%)

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 24 quarters, 269.88 Cr → 643.91 Cr (in ₹), with an average increase of 3.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 19 quarters, 74.95 Cr → 176.91 Cr (in ₹), with an average increase of 4.6% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 21.14% to 21.18% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.02% to 2.03% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 11.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 36.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.57% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.15% to 5.75% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CAPLIPOINT stock has moved down by -5.6%

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Revenue: ₹610.36Cr as on June 2026 (Q1 FY27)
Net Profit: ₹179.09Cr as on June 2026 (Q1 FY27)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOC C Paarthipan
E-voting on sharesClick here to vote

FAQs

What is Caplin Point Laboratories share price today?

Caplin Point Laboratories share price today stands at ₹2583 as on at the close of the market. Caplin Point Laboratories share today touched a day high of ₹2606.7 and a low of ₹2490.5.

What is the 52 week high and 52 week low range for Caplin Point Laboratories share?

Caplin Point Laboratories touched a 52 week high of ₹2877.3 and a 52 week low of ₹1500.3. Caplin Point Laboratories share price today i.e. is closed at ₹2583, which is -10.23% down from its 52 week high and 72.17% up from its 52 week low.

What is Caplin Point Laboratories's market capitalisation today?

Caplin Point Laboratories market capitalisation is ₹19,539.57 Cr as on .

How to buy Caplin Point Laboratories shares?

To buy Caplin Point Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for CAPLIPOINT or Caplin Point Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Caplin Point Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Caplin Point Laboratories trading volume today?

Caplin Point Laboratories trading volume is 2.12L as on . This means that 2.12L shares of Caplin Point Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Caplin Point Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Caplin Point Laboratories have both increased over the past 30 days, and the average INDmoney investor holds the stock for 42 days. This reflects platform activity only and is not investment advice.